1 / 44

Immunodeficiency

Immunodeficiency. Mitzi Nagarkatti Professor and Chair Dept. Pathology, Microbiology and Immunology USC School of Medicine Deputy Director, USC Cancer Center Tel. # (803)733-3275 E-mail: mnagark@uscmed.sc.edu. Objectives. Definition Primary Immunodeficiencies Characteristics

Download Presentation

Immunodeficiency

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Immunodeficiency Mitzi Nagarkatti Professor and Chair Dept. Pathology, Microbiology and Immunology USC School of Medicine Deputy Director, USC Cancer Center Tel. # (803)733-3275 E-mail: mnagark@uscmed.sc.edu

  2. Objectives • Definition • Primary Immunodeficiencies • Characteristics • Types of primary immunodeficiency disorders • Mode of inheritance • Diagnosis and Treatment • Secondary Immunodeficiency • Human Immunodeficiency Virus • Transmission • Therapy and prevention of AIDS

  3. Immunodeficiency Defect in 1 or more components of immune system Types: • Primary or Congenital: • Born with the immunodeficiency • Inherited (Mutation in gene controlling immune cells) • Susceptible to recurrent and severe infections • Start in childhood • Cannot recover without treatment • >125 immunodeficiency disorders • Secondary or Acquired: As a consequence of other diseases, drugs or environmental factors (e.g. infection, malignancy, aging, starvation, medication, drugs) – Human Immunodeficiency Virus

  4. Hematopoiesis Progenitor Progenitor

  5. Hematopoietic Stem Cell (HSC) deficiency • HSC are multipotent (differentiate into all blood cell types) • Self renewing cells • Lineage negative (mature B/T cell, granulocyte, Mf markers absent) • CD34+, c-Kit+, Stem cell Ag (Sca-1+) on cell surface • Defect in HSC results in immunodeficiency known as Reticular Dysgenesis • Affects development of all leukocytes • Patients are susceptible to all infections (bacterial, viral, parasitic and fungal) • Fatal without treatment • Treated with bone marrow or HSC transplantation

  6. Thymus TCR HSC T cell MHC MHC MHC Thymic Stromal Cells HSC HSC Thymus Allogeneic BM/HSC Transplantation MHC MHC TCR Success depends on T cell depletion and MHC-matching

  7. Defects in Myeloid Lineage Progenitor Progenitor

  8. Myeloid Progenitor Cell Differentiation Defect • Myeloid Progenitor Cells develop into neutrophils and monocytes • Defect in differentiation from myeloid progenitor cells into neutrophils results in Congenital Agranulocytosis • Recurrent bacterial infections seen in patients • Treated with granulocyte-macrophage colony stimulating factor (GM-CSF) or granulocyte colony stimulating factor (G-CSF)

  9. Defective Neutrophils • Patients have neutrophils that are defective in production of reactive oxygen species that is responsible for killing of phagocytosed microrganisms. • Nitroblue tetrazolium test: reduction by superoxide (-ve) • This results in accumulation of granulocytes, Mf and T cells forming granulomas. These patients suffer from Chronic Granulomatous Disease. • Have recurrent bacterial infections • Commensals can become pathogenic • X-linked or autosomal recessive • Treated with IFN-g against infections

  10. Inheritance • 22 pairs of autosomes and 1 pair of sex chromosomes (X and Y) • Autosomal recessive (most AA normal; Aa carrier; aa affected) • Autosomal dominant (Aa affected; aa is normal) • X-linked (XX carrier daughter; XY affected son) Carrier x Normal Mother Father Xx XY Carrier x Carrier Mother Father Aa Aa Normal x Affected Mother Father aa Aa Autosomal Recessive Autosomal Dominant X-linked

  11. Leukocyte Adhesion deficiency • Adhesion molecule (e.g. CD18) may be lacking on T cells and monocytes. • Autosomal recessive • Results in defective leukocyte extravasation from blood to sites of infection • Recurrent infections • Impaired wound healing • Treated with BM (depleted of T cells and HLA matched) transplantation or with gene therapy

  12. Defects in Lymphoid Lineage Progenitor Progenitor

  13. Defect in Lymphoid Progenitor • Results in Severe Combined Immunodeficiency (SCID) • Lack T, B and/or NK cells • Thymus does not develop • Myeloid and erythroid cells are normal. • Generally lethal • Susceptible to bacterial, viral and fungal infections. • In infants, passively transferred maternal Abs are present. • Live attenuated vaccines (e.g. Sabin polio) can cause disease.

  14. Types of SCID TCR • RAG-1/2 (Recombinase activating gene) deficiency: Required for TCR and Ig gene rearrangement • IL-2R gene defect • Adenosine deaminase (ADA) deficiency Adenosine Inosine Uric acid T, B and NK cell deficiency due to toxicity of accumulated metabolites First successful gene therapy done in patient with ADA Ig B cells T cells T cells/ NK cells IL-2 receptor IL-2 ADA

  15. Defect in T cell development Progenitor Progenitor

  16. DiGeorge syndrome

  17. Precursor T cell differentiation defect • Athymic - DiGeorge Syndrome • Lack of T helper (Th) cells , Cytotoxic T cells (CTL) and T regulatory (Treg) cells • B cells are present but T-dependent B cell responses are defective • Anti-viral and anti-fungal immunity impaired • Developmental defect in the 3rd and 4th pharyngeal pouch • Results in facial defect and congenital heart disease • Treated with thymic transplant • Autosomal dominant trait

  18. Nude Athymic mouse nu/nu gene (autosomal recessive) Hairless Should be maintained in pathogen-free environment T helper cell defect Results in impaired cytotoxic T cell activity and Th-dependent B cell responses due to Th cell defect Accept xenografts

  19. Defects in B cell development Progenitor Progenitor

  20. X-linked Agammaglobulinemia (x-LA) Hyper IgM Syndrome Pre B cells • Absence of Igs and B cells • Arrest at Pre-B cell stage (H-chain rearranged but not L chain) • Deficiency in IgG, IgA and IgE • Increased IgM in serum • B cells express IgD and IgM on membrane • X-linked • Recurrent infections • e.g. IgA deficiency • Due to defect in isotype switching • Recurrent respiratory, gastrointestinal and/or genitourinary infection x-LA Mature B cells Selective Ig class deficiency Proliferation IgM Isotype switching Differentiation CVD Plasma cells IgA def.

  21. Common Variable Immunodeficiency Pre B cells • B cells are normal • Defect in maturation to plasma cells • Decreased IgM, IgG and IgA or only IgG and IgA • Susceptible to bacterial (e.g. pneumococci) infections • Low Ab titers against DPT or MMR Vaccines • Usually not detected in children because of passively transferred maternal Abs • Also called Late-onset hypogammaglobulinemia, Adult-onset agammaglobulinemia or Acquired agammaglobulinemia • Ig replacement therapy and antibiotics x-LA Mature B cells Proliferation IgM Isotype switching Differentiation CVD Plasma cells IgA def.

  22. Other Immunodeficiencies • Bare lymphocyte syndrome: Lack MHC class II on B cells, macrophages and dendritic cells • Complement Deficiency

  23. Overview of Primary Immunodeficiencies DiGeorge Syndrome SCID Common Variable Hypogglobulinemia/ X-linked hyperIgM Syndrome/Selective Ig deficiency Progenitor xLA Reticular Dysgenesis Progenitor Congenital Agranulocytosis Chronic Granulomatous Disease

  24. Adaptive Immunity Deficiency • T cell deficiency • Cell-mediated immunity is absent and thus are susceptible to viral, parasitic and fungal infection • Susceptible to intracellular bacterial infection e.g. Salmonella typhi, Mycobacteria • Can produce primary IgM response • Fail to mount a secondary IgG response because it is T helper cell-dependent • Cannot produce Abs to T-dependent antigens such as tetanus toxoid • B cell deficiency • Susceptible to extracellular bacterial infection e.g. Staphylococcal, pneumococcal infection • Fail to mount a humoral immune response. • Immunity against viruses, parasites and bacteria is intact

  25. Secondary or Acquired Immunodeficiencies • Agent-induced immunodeficiency: e.g. infections including HIV • Metabolic disorders and trauma • Drugs such as corticosteroids, cyclosporin A, radiation and chemotherapy • Aging

  26. Human Immunodeficiency Virus • Discovered in 1983 by Luc Montagnier and Robert Gallo • Is a member of genus retrovirus (RNA virus) belonging to Lentiviridae • Characterized by long incubation period and slow course of disease • HIV-1 (Common in US) and HIV-2 (in Africa) • Patients with low CD4+ T cells • Virus prevalent in homosexual, promiscuous heterosexual, i.v. drug users, transfusion, infants born to infected mothers • Opportunistic infections with Pnuemocystis carinii, Candida albicans, Mycobacterium avium, etc. • Patients with HIV have high incidence of cancers such as Kaposi sarcoma

  27. Candidiasis

  28. Kaposi Sarcoma

  29. Controversy • Luc Montagnier won Nobel Prize but not William Paul • Duesberg Hypothesis: Peter Duesberg (Univ. California, Berkeley) believed AIDS is caused by non-infectious factors such as drugs of abuse of HIV is a passenger virus. • HIV originated from SIV. Transmitted by scientists working with monkeys and chimpanzees from Africa which carry SIV.

  30. Incidence of HIV CDC 2008

  31. Course of AIDS Dissemination of virus; Seeding of lymphoid organs Anti-HIV Ab/CTL ACUTE CHRONIC AIDS PHASE PHASE (<200cells/mm3)

  32. Structure of HIV env (Envelope) (p24) (p17) Protease Matrix Capsid Integrase gag pol

  33. Abs are ineffective to control HIV • Virus grows intracellularly • Abs develop after ~3 weeks. Thus cannot be used as a diagnostic test initially • Reverse transcriptase is a sensitive test for diagnosis. • Abs are not neutralizing

  34. Role of T cells in development of AIDS • Initially Th cells control viral load • Cytopathic virus • Syncitium formation with infected/uninfected cells • Surviving Th cells are anergic • Destruction of infected Th cells by CTL • CTL that develop are ineffective because of high viral mutations • Lack of Th affects CTL activation • Resistance to CTL by downregulation of class I MHC on target cells

  35. Animal Models • Primate Model: • HIV grows in chimpanzees but do not develop AIDS • Simian immunodeficiency virus (SIVagm in African green monkey – no disease; SIVmac in Macaques – AIDS like disease) • Feline immunodeficiency virus (FIV) • Mouse Model: • Grows in Severe Combined Immunodeficiency (SCID) mice reconstituted with human lymphocytes

  36. Viral Replication

  37. Coreceptors of HIV:In addition to gp120 binding to CD4, HIV has to bind coreceptors to gain entry into the cells. These coreceptors also serve as receptors for chemokines. • Chemokine receptors • T cell-tropic (Syncitium-inducing; X4 virus strain) • Macrophage-tropic (Nonsyncitium-inducing; R5 virus strain) CXCR4: Ligand is SDF1 (Stromal cell derived factor) CD4 CD4 CCR5: Ligands are RANTES (Regulated on activation, normal T cell expressed and secreted), MIP1a, MIP1b (Macrophage Inflammatory Protein)

  38. Therapeutic targets Inhibit binding Kuby, 2007

  39. Therapy • Inhibit binding of gp120 with CD4 by • Use of soluble CD4 • Use of anti-CD4 Abs • Use of anti-gp120 • Inhibit binding of HIV to coreceptors by chemokines such as RANTES and SDF-1 or their mimics

  40. Host Factors influencing course • Transmission of HIV • Sexual contact • Breast feeding • Transfusion • During birth • Sharing needles • Resistance to HIV in individuals • CCR5D32 • Some HLA types (HLA-A2) are resistant while others (HLA-B35) are susceptible)

  41. Treatment and Prevention • Highly active anti-retroviral therapy (HAART; combination therapy) + IL-2 (to reconstitute the immune system) • Vaccines: Proteins, DNA, subunit and recombinant virus (SIV-HIV chimeric virus )

  42. Problems with therapy • HIV-1 infection gives rise to AIDS despite the presence of Abs • Low immunogenicity of virus • Vaccine alone leads to destruction of CD4+ T cells • Integration of virus in host genome • Virus undergoes mutations • High rate of virus replication (109 viruses/day) • Live attenuated virus may result in AIDS • Heat killed organism is not antigenic • Vaccine administered through oral or respiratory route (Route of exposure to HIV is through genital tract) • Lack of animal models and in vitro testing system • Drugs do not cross blood-brain barrier to reach virus in brain

  43. Summary • Primary immunodeficiencies are inherited • They can affect hematopoietic stem cells, lymphoid or myeloid cells. • Secondary immunodeficiencies are due to infections, aging, cancer or chemical exposure • HIV affects immune system by eliminating CD4+ T cells • Vaccine development has been hindered by lack of an experimental model, antigenic variation, rapid proliferation of the virus, etc.

  44. Reading • Immunology By Male, Brostoff, Roth and Roitt 7th Edition Pages299-324

More Related